SEC Form D · filed February 23, 2022
MINERVA BIOTECHNOLOGIES Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Joseph A. Nathan · Waltham, MADirectorKenneth Kosik · Waltham, MADirectorRobert Staszewski · Waltham, MADirectorRonald R. Axelrod · Waltham, MADirectorKenneth A. Reed · Waltham, MADirectorJames R. Bridges · Waltham, MADirectorLawrence A. Coolidge · Waltham, MADirectorCynthia Bamdad · Waltham, MAExec · DirectorTaylor Hobbs · Waco, TXDirectorBrandon Jundt · Denver, COExec · DirectorJames V. O'Donnell · Saint Louis, MODirectorSharon C. Geraghty · Winnepeg, Manitoba, CanadaDirectorLowell J. Burnett · San Diego, CADirectorBrent Eley · Bellevue, WADirectorMilton Pinsky · Northbrook, ILExec · DirectorBrad Sargent · Cupertino, CADirectorMichael Cassara · San Diego, CADirectorBenjamin Alfonsi · New York, NYDirectorMichael Skead · Vancouver, British Columbia, CanadaDirectorFrank C. Foster · Santa Barbara, CADirectorAndrew Rosen · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗